REFERENCES
1. Zhang H, Sun Y, Liu R, et al. The role of tumor microenvironment and signaling pathways in regulating breast cancer stem cells: Implications for therapy resistance and tumor recurrence. Drug Resist Updat. 2026;84:101315.
2. Fan H, Xu C, He S, Wang J, Zhu H, Shu K. Mechanical regulation of microenvironment remodeling in brain tumors: from mechanism to therapy. J Neuroinflammation. 2026;23:225.
3. Papavassiliou KA, Basdra EK, Papavassiliou AG. The emerging promise of tumour mechanobiology in cancer treatment. Eur J Cancer. 2023;190:112938.
4. Alushin GM, Connolly SM, Njoku BC. Structural biophysics of cytoskeletal force transduction. Annu Rev Cell Dev Biol. 2026;Epub ahead of print.
5. Yang L, Akbarabadi P, Babashah S. Cancer-associated fibroblasts-derived exosomes in colorectal cancer progression: mechanism and therapeutic opportunities. Biochim Biophys Acta Rev Cancer. 2026;1881:189545.
6. Zhai H, Sun P, Bashir B, et al. Autophagy in thyroid cancer: Immune suppression and drug resistance. Drug Resist Updat. 2026;88:101437.
7. Huang M, Chen Y, Liang C, et al. Drug resistant cancer cells show increased nuclear mechanotransduction and mechanically targetable YAP-regulated vulnerability. Biomaterials. 2026;329:123920.
8. Ji X, Zhang J, Qiu Y, et al. Visualization of mechanical force regulation of exosome secretion using high time-spatial resolution imaging. Anal Chem. 2025;97:1210-20.
9. Swartz MA, Lund AW. Lymphatic and interstitial flow in the tumour microenvironment: linking mechanobiology with immunity. Nat Rev Cancer. 2012;12:210-9.
10. Zhu Y, Chen J, Chen C, et al. Deciphering mechanical cues in the microenvironment: from non-malignant settings to tumor progression. Biomark Res. 2025;13:11.
11. Luo CW, Wu CC, Ch'ang HJ. Radiation sensitization of tumor cells induced by shear stress: the roles of integrins and FAK. Biochim Biophys Acta. 2014;1843:2129-37.
12. Dattachoudhury S, Sharma A, Sharma R, Pal S, Sukumar P, Jaganathan BG. Downregulation of PIEZO1 activity promotes breast cancer cell survival under shear stress by modulating β-catenin and BCL2. Cancer Res Commun. 2026;6:1557-72.
13. Karasová M, Jobst M, Framke D, et al. Mechanical cues rewire lipid metabolism and support chemoresistance in epithelial ovarian cancer cell lines OVCAR3 and SKOV3. Cell Commun Signal. 2025;23:193.
14. Nath S, Pigula M, Khan AP, et al. Flow-induced shear stress confers resistance to carboplatin in an adherent three-dimensional model for ovarian cancer: a role for EGFR-targeted photoimmunotherapy informed by physical stress. J Clin Med. 2020;9:924.
15. Feng T, Li B, Zhang C, et al. Fluid shear stress-mediated upregulated exosomal-IGF2 promotes hepatocellular carcinoma cell migration and metastasis. Am J Cancer Res. 2025;15:4570-85.
16. Chen X, Xia Q, Sun N, et al. Shear stress enhances anoikis resistance of cancer cells through ROS and NO suppressed degeneration of Caveolin-1. Free Radic Biol Med. 2022;193:95-107.
17. Wang K, Wei Y, Liu W, et al. Mechanical stress-dependent autophagy component release via extracellular nanovesicles in tumor cells. ACS Nano. 2019;13:4589-602.
18. Yamashita T, Nagamoto S, Arai M, Kitayama S, Yano A, Higashi M. Metabolic and molecular mechanisms of gemcitabine resistance in urothelial carcinoma. Cancers. 2026;18:2126.
19. Wright K, Ly T, Kriet M, Czirok A, Thomas SM. Cancer-associated fibroblasts: master tumor microenvironment modifiers. Cancers. 2023;15:1899.
20. LeSavage BL, Zhang D, Huerta-López C, et al. Engineered matrices reveal stiffness-mediated chemoresistance in patient-derived pancreatic cancer organoids. Nat Mater. 2024;23:1138-49.
21. Ren R, Zhang S, Peng Z, et al. Matrix stiffness regulates glucose-6-phosphate dehydrogenase expression to mediate sorafenib resistance in hepatocellular carcinoma through the ITGB1-PI3K/AKT pathway. Cell Death Dis. 2025;16:538.
22. Yan J, Wu D, Zhu B, et al. 3D printed GelMA/HAMA based mechanical microenvironment boosted PDAC chemoresistance via NRF2-repressed ferroptosis. Colloids Surf B Biointerfaces. 2025;254:114816.
23. Wu B, Liu DA, Guan L, et al. Stiff matrix induces exosome secretion to promote tumour growth. Nat Cell Biol. 2023;25:415-24.
24. Liu Z, Jin Q, Yan T, Wo Y, Liu H, Wang Y. Exosome-mediated transduction of mechanical force regulates prostate cancer migration via microRNA. Biochem Biophys Rep. 2022;31:101299.
25. Röhrig F, Vorlová S, Hoffmann H, et al. VEGF-ablation therapy reduces drug delivery and therapeutic response in ECM-dense tumors. Oncogene. 2017;36:1-12.
26. Biancacci I, De Santis D, Rama E, et al. Repurposing tamoxifen for tumor microenvironment priming and enhanced tumor-targeted drug delivery. Adv Ther. 2023;6:adtp.
27. Sun Y, Yin Z, Li S, et al. Losartan rewires the tumor-immune microenvironment and suppresses IGF-1 to overcome resistance to chemo-immunotherapy in ovarian cancer. Br J Cancer. 2024;131:1683-93.
28. Burchard PR, Ruffolo LI, Ullman NA, et al. Pan-lysyl oxidase inhibition disrupts fibroinflammatory tumor stroma, rendering cholangiocarcinoma susceptible to chemotherapy. Hepatol Commun. 2024;8:e0502.
29. Hou X, Shen Y, Huang B, et al. Losartan-based nanocomposite hydrogel overcomes chemo-immunotherapy resistance by remodeling tumor mechanical microenvironment. J Nanobiotechnology. 2024;22:667.
30. Van Cutsem E, Tempero MA, Sigal D, et al.; HALO 109-301 Investigators. Randomized phase III trial of pegvorhyaluronidase alfa with nab-paclitaxel plus gemcitabine for patients with hyaluronan-high metastatic pancreatic adenocarcinoma. J Clin Oncol. 2020;38:3185-94.
31. Stylianopoulos T, Martin JD, Chauhan VP, et al. Causes, consequences, and remedies for growth-induced solid stress in murine and human tumors. Proc Natl Acad Sci U S A. 2012;109:15101-8.
32. Safaei S, Sajed R, Shariftabrizi A, et al. Tumor matrix stiffness provides fertile soil for cancer stem cells. Cancer Cell Int. 2023;23:143.
33. Rizzuti IF, Mascheroni P, Arcucci S, et al. Mechanical control of cell proliferation increases resistance to chemotherapeutic agents. Phys Rev Lett. 2020;125:128103.
34. Martino F, Perestrelo AR, Vinarský V, Pagliari S, Forte G. Cellular mechanotransduction: from tension to function. Front Physiol. 2018;9:824.
35. Cascione M, De Matteis V, Toma CC, Pellegrino P, Leporatti S, Rinaldi R. Morphomechanical and structural changes induced by ROCK inhibitor in breast cancer cells. Exp Cell Res. 2017;360:303-9.
36. Shao B, Bu H, Li G, Kang D, Ju Q. Autophagy-dependent apoptosis induction by oridonin are mediated by ROS-dependent AMPK-mTOR-ULK1 pathway in colon cancer. Am J Cancer Res. 2025;15:1902-18.
37. Yu W, Zhang C, Wang Y, et al. YAP 5-methylcytosine modification increases its mRNA stability and promotes the transcription of exosome secretion-related genes in lung adenocarcinoma. Cancer Gene Ther. 2023;30:149-62.
38. Huang HM, Han CS, Cui SJ, et al. Mechanical force-promoted osteoclastic differentiation via periodontal ligament stem cell exosomal protein ANXA3. Stem Cell Reports. 2022;17:1842-58.
39. Yu Q, Guo K, Yang Y, et al. Fibroblast-derived exosomes induce macrophage pyroptosis to mediate orthodontic bone remodeling through the mtDNA/NLRP3 axis. J Nanobiotechnology. 2026;24:381.
40. Huang J, Wei W, Kang F, et al. ANXA3, associated with YAP1 regulation, participates in the proliferation and chemoresistance of cervical cancer cells. Genes Genomics. 2023;45:1575-86.
41. Soliman BG, Tian P, Cui J, Kilian KA, Gooding JJ. Interfacial stress regulates plasticity and drug resistance at the breast cancer-host interface. Adv Sci. 2025;12:e09361.
42. Cao M, Li Y, Su X, et al. Exosome-derived lnc-FAM72D-3 promotes lenvatinib resistance by remodeling hepatocellular carcinoma cytoskeleton via MBNL1/FAK axis. Drug Resist Updat. 2025;82:101271.
43. Momotyuk E, Ebrahim N, Shakirova K, Dashinimaev E. Role of the cytoskeleton in cellular reprogramming: effects of biophysical and biochemical factors. Front Mol Biosci. 2025;12:1538806.
44. Xie N, Xiao C, Shu Q, et al. Cell response to mechanical microenvironment cues via Rho signaling: from mechanobiology to mechanomedicine. Acta Biomater. 2023;159:1-20.
45. van Niel G, D’Angelo G, Raposo G. Shedding light on the cell biology of extracellular vesicles. Nat Rev Mol Cell Biol. 2018;19:213-28.
46. Hessvik NP, Llorente A. Current knowledge on exosome biogenesis and release. Cell Mol Life Sci. 2018;75:193-208.
47. Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020;367:eaau6977.
48. Yang S, Zhang X, Chen B, et al. Research progress on the interaction mechanisms and functions between exosomes and the cytoskeleton. Front Cell Dev Biol. 2026;14:1718115.
49. Ding B, Yang S, Schaks M, et al. Structures reveal a key mechanism of WAVE regulatory complex activation by Rac1 GTPase. Nat Commun. 2022;13:5444.
50. Latifkar A, Cerione RA, Antonyak MA. Probing the mechanisms of extracellular vesicle biogenesis and function in cancer. Biochem Soc Trans. 2018;46:1137-46.
51. Sinha S, Hoshino D, Hong NH, et al. Cortactin promotes exosome secretion by controlling branched actin dynamics. J Cell Biol. 2016;214:197-213.
52. Croisé P, Estay-Ahumada C, Gasman S, Ory S. Rho GTPases, phosphoinositides, and actin: a tripartite framework for efficient vesicular trafficking. Small GTPases. 2014;5:e29469.
53. Song Z, Cui Y, Xin L, et al. Mechano-oncogenic cytoskeletal remodeling drives leukemic transformation with mitochondrial vesicle-mediated STING activation. Cell Stem Cell. 2025;32:581-97.e11.
54. Nagpal S, Swaminathan K, Beaudet D, et al. Optogenetic control of kinesin-1, -2, -3 and dynein reveals their specific roles in vesicular transport. Cell Rep. 2024;43:114649.
55. Robinson BP, Bass NR, Bhakt P, Spiliotis ET. Septin-coated microtubules promote maturation of multivesicular bodies by inhibiting their motility. J Cell Biol. 2024;223:e202308049.
56. Shi L, Jian Y, Li M, Hao T, Yang C, Wang X. Filamin FLN-2 promotes MVB biogenesis by mediating vesicle docking on the actin cytoskeleton. J Cell Biol. 2022;221:e202201020.
57. Salas-Cortes L, Ye F, Tenza D, et al. Myosin Ib modulates the morphology and the protein transport within multi-vesicular sorting endosomes. J Cell Sci. 2005;118:4823-32.
58. Qiu X, Campos Y, van de Vlekkert D, et al. Distinct functions of dimeric and monomeric scaffold protein Alix in regulating F-actin assembly and loading of exosomal cargo. J Biol Chem. 2022;298:102425.
59. Phuyal S, Farhan H. Multifaceted Rho GTPase signaling at the endomembranes. Front Cell Dev Biol. 2019;7:127.
60. Asare-Werehene M, Nakka K, Reunov A, et al. The exosome-mediated autocrine and paracrine actions of plasma gelsolin in ovarian cancer chemoresistance. Oncogene. 2020;39:1600-16.
61. Sun Q, Jin L, Dong S, Zhang L. LRRC59 promotes the progression of oral squamous cell carcinoma by interacting with SRP pathway components and enhancing the secretion of CKAP4-containing exosomes. Heliyon. 2024;10:e28083.
62. Ma X, Liu K, Li J, et al. A non-canonical GTPase interaction enables ORP1L-Rab7-RILP complex formation and late endosome positioning. J Biol Chem. 2018;293:14155-64.
63. Li H, De Santis MC, Tucci FA, et al. SH3BP5L triggers the RAB11A-regulated integrin recycling network implicated in breast cancer metastasis. J Clin Invest. 2026;136:e192705.
64. Kurowska M, Goudin N, Nehme NT, et al. Terminal transport of lytic granules to the immune synapse is mediated by the kinesin-1/Slp3/Rab27a complex. Blood. 2012;119:3879-89.
65. Serra-Marques A, Martin M, Katrukha EA, et al. Concerted action of kinesins KIF5B and KIF13B promotes efficient secretory vesicle transport to microtubule plus ends. Elife. 2020;9:e61302.
66. Huang B, Deng X, Zhou G, et al. SYT4 binds to SNAP25 to facilitate exosomal secretion and prostate cancer enzalutamide resistance. Cancer Sci. 2024;115:2630-45.
67. Mason JD, Marks E, Fan SJ, et al. Stress-induced Rab11a-exosomes induce amphiregulin-mediated cetuximab resistance in colorectal cancer. J Extracell Vesicles. 2024;13:e12465.
68. Hussein NA, Malla S, Pasternak MA, et al. The role of endolysosomal trafficking in anticancer drug resistance. Drug Resist Updat. 2021;57:100769.
69. Shoji T, Shinojima A, Kishimoto T, et al. A PI(3,5)P2/CHMP4B axis on lysosomes is essential for microautophagic degradation of STING. Nat Commun. 2026;17:4602.
70. Yang Z, Li X, Lin Q, et al. Cortical actin depolymerisation in 3D cell culture enhances extracellular vesicle secretion and therapeutic effects. J Extracell Vesicles. 2025;14:e70109.
71. Hinze C, Boucrot E. Local actin polymerization during endocytic carrier formation. Biochem Soc Trans. 2018;46:565-76.
72. Hoshino D, Kirkbride KC, Costello K, et al. Exosome secretion is enhanced by invadopodia and drives invasive behavior. Cell Rep. 2013;5:1159-68.
73. Tian J, Zhang L, La X, Fan X, Li Z. MiR-769-5p of macrophage exosomes induced by GRP78 promotes stemness and chemoresistance in colorectal cancer. Cell Death Dis. 2025;16:156.
74. Zhan Y, Zhou Z, Zhu Z, et al. Exosome-transmitted LUCAT1 promotes stemness transformation and chemoresistance in bladder cancer by binding to IGF2BP2. J Exp Clin Cancer Res. 2025;44:80.
75. Hu JH, Tang HN, Wang YH. Cancer-associated fibroblast exosome LINC00355 promotes epithelial-mesenchymal transition and chemoresistance in colorectal cancer through the miR-34b-5p/CRKL axis. Cancer Gene Ther. 2024;31:259-72.
76. Nakayama T, Kamiguchi H, Akagawa K. Syntaxin 1C, a soluble form of syntaxin, attenuates membrane recycling by destabilizing microtubules. J Cell Sci. 2012;125:817-30.
77. Ramirez C, Hauser AD, Vucic EA, Bar-Sagi D. Plasma membrane V-ATPase controls oncogenic RAS-induced macropinocytosis. Nature. 2019;576:477-81.
78. Mulcahy LA, Pink RC, Carter DR. Routes and mechanisms of extracellular vesicle uptake. J Extracell Vesicles. 2014;3:24641.
79. Zhao G, Zhang Y, Zhang H, et al. Tumor-derived exosomal tsRNA 3’tiRNA-AlaCGC in promoting fibroblast senescence and Galectin-9 secretion to induce immune tolerance in lung adenocarcinoma. Cell Death Discov. 2025;11:403.
80. Han H, Li Y, Lin Z, et al. Exosomal miR-130a-3p confers cisplatin resistance in esophageal cancer by regulating ferroptosis via the suppression of METTL14-mediated m6A RNA methylation of FSP1. Int Immunopharmacol. 2025;146:113804.
81. Abad E, Lyakhovich A. Movement of mitochondria with mutant DNA through extracellular vesicles helps cancer cells acquire chemoresistance. ChemMedChem. 2022;17:e202100642.
82. Mostafazadeh M, Samadi N, Kahroba H, Baradaran B, Haiaty S, Nouri M. Potential roles and prognostic significance of exosomes in cancer drug resistance. Cell Biosci. 2021;11:1.
83. Panda SK, Sanchez-Pajares IR, Rehman A, et al. ER stress and/or ER-phagy in drug resistance? Three coincidences are proof. Cell Commun Signal. 2025;23:223.
84. Hassanpour M, Rezabakhsh A, Rezaie J, Nouri M, Rahbarghazi R. Exosomal cargos modulate autophagy in recipient cells via different signaling pathways. Cell Biosci. 2020;10:92.
85. Zubkova E, Kalinin A, Bolotskaya A, Beloglazova I, Menshikov M. Autophagy-dependent secretion: crosstalk between autophagy and exosome biogenesis. Curr Issues Mol Biol. 2024;46:2209-35.
86. Liu J, Wu P, Li D, et al. Autophagy in cancer - functional plasticity, therapeutic paradox, and the road to precision modulation: a comprehensive review. Mol Cancer. 2026;Epub ahead of print.
87. Chen S, Guan JL. Tumor-promoting and -suppressive roles of autophagy in the same mouse model of BrafV600E-driven lung cancer. Cancer Discov. 2013;3:1225-7.
88. Kaminskyy VO, Piskunova T, Zborovskaya IB, Tchevkina EM, Zhivotovsky B. Suppression of basal autophagy reduces lung cancer cell proliferation and enhances caspase-dependent and -independent apoptosis by stimulating ROS formation. Autophagy. 2012;8:1032-44.
89. Goler-Baron V, Sladkevich I, Assaraf YG. Inhibition of the PI3K-Akt signaling pathway disrupts ABCG2-rich extracellular vesicles and overcomes multidrug resistance in breast cancer cells. Biochem Pharmacol. 2012;83:1340-8.
90. Visan KS, Lobb RJ, Moller A. The role of exosomes in the promotion of epithelial-to-mesenchymal transition and metastasis. Front Biosci. 2020;25:1022-57.
91. Guo H, Chitiprolu M, Roncevic L, et al. Atg5 Disassociates the V1V0-ATPase to promote exosome production and tumor metastasis independent of canonical macroautophagy. Dev Cell. 2017;43:716-30.e7.
92. Bhattacharya S, Pal K, Sharma AK, et al. GAIP interacting protein C-terminus regulates autophagy and exosome biogenesis of pancreatic cancer through metabolic pathways. PLoS One. 2014;9:e114409.
93. Fan SJ, Kroeger B, Marie PP, et al. Glutamine deprivation alters the origin and function of cancer cell exosomes. EMBO J. 2020;39:e103009.
94. Tan HWS, Sim AYL, Long YC. Glutamine metabolism regulates autophagy-dependent mTORC1 reactivation during amino acid starvation. Nat Commun. 2017;8:338.
95. Zhang LH, Yang AJ, Wang M, et al. Enhanced autophagy reveals vulnerability of P-gp mediated epirubicin resistance in triple negative breast cancer cells. Apoptosis. 2016;21:473-88.
96. Li Y, Yin Y, Zhang T, et al. A comprehensive landscape analysis of autophagy in cancer development and drug resistance. Front Immunol. 2024;15:1412781.
97. Zhu S, Mao J, Zhang X, et al. CAF-derived exosomal lncRNA FAL1 promotes chemoresistance to oxaliplatin by regulating autophagy in colorectal cancer. Dig Liver Dis. 2024;56:330-42.
98. Guo H, Sadoul R, Gibbings D. Autophagy-independent effects of autophagy-related-5 (Atg5) on exosome production and metastasis. Mol Cell Oncol. 2018;5:e1445941.
99. Backer JM. The regulation and function of Class III PI3Ks: novel roles for Vps34. Biochem J. 2008;410:1-17.
100. Sasaki K, Tsuno NH, Sunami E, et al. Chloroquine potentiates the anti-cancer effect of 5-fluorouracil on colon cancer cells. BMC Cancer. 2010;10:370.
101. Geng X, Li L, Luo Y, et al. Tumor cell derived lnc-FSD2-31:1 contributes to cancer-associated fibroblasts activation in pancreatic ductal adenocarcinoma progression through extracellular vesicles cargo MiR-4736. Adv Sci. 2023;10:e2203324.
102. Sung JS, Kang CW, Kang S, et al. ITGB4-mediated metabolic reprogramming of cancer-associated fibroblasts. Oncogene. 2020;39:664-76.
103. Kucharzewska P, Christianson HC, Welch JE, et al. Exosomes reflect the hypoxic status of glioma cells and mediate hypoxia-dependent activation of vascular cells during tumor development. Proc Natl Acad Sci U S A. 2013;110:7312-7.
104. Liu DX, Li PP, Guo JP, et al. Exosomes derived from HBV-associated liver cancer promote chemoresistance by upregulating chaperone-mediated autophagy. Oncol Lett. 2019;17:323-31.
105. Yuwen D, Ma Y, Wang D, et al. Prognostic role of circulating exosomal miR-425-3p for the response of NSCLC to platinum-based chemotherapy. Cancer Epidemiol Biomarkers Prev. 2019;28:163-73.
106. Kulkarni B, Gondaliya P, Kirave P, et al. Exosome-mediated delivery of miR-30a sensitize cisplatin-resistant variant of oral squamous carcinoma cells via modulating Beclin1 and Bcl2. Oncotarget. 2020;11:1832-45.
107. Pan Z, Zheng J, Zhang J, et al. A novel protein encoded by exosomal circATG4B induces oxaliplatin resistance in colorectal cancer by promoting autophagy. Adv Sci. 2022;9:e2204513.
108. Zhang C, Wang Y, Zhen Z, Li J, Su J, Wu C. mTORC1 mediates biphasic mechano-response to orchestrate adhesion-dependent cell growth and anoikis resistance. Adv Sci. 2024;11:e2307206.
109. Cruz da Silva E, Dontenwill M, Choulier L, Lehmann M. Role of integrins in resistance to therapies targeting growth factor receptors in cancer. Cancers. 2019;11:692.
110. Gao Y, Wei G, Yu H, et al. Integrin β6/Annexin A2 axis triggers autophagy to orchestrate hepatocellular carcinoma radioresistance. Cell Death Differ. 2025;32:689-701.
111. Morosi L, Meroni M, Ubezio P, et al. PEGylated recombinant human hyaluronidase (PEGPH20) pre-treatment improves intra-tumour distribution and efficacy of paclitaxel in preclinical models. J Exp Clin Cancer Res. 2021;40:286.
112. Whatcott CJ, Han H, Posner RG, Hostetter G, Von Hoff DD. Targeting the tumor microenvironment in cancer: why hyaluronidase deserves a second look. Cancer Discov. 2011;1:291-6.
113. Pavel M, Renna M, Park SJ, et al. Contact inhibition controls cell survival and proliferation via YAP/TAZ-autophagy axis. Nat Commun. 2018;9:2961.
114. Que K, Tong Y, Que G, et al. Downregulation of miR-874-3p promotes chemotherapeutic resistance in colorectal cancer via inactivation of the Hippo signaling pathway. Oncol Rep. 2017;38:3376-86.
115. Putra VDL, Kilian KA, Knothe Tate ML. Stem cell mechanoadaptation. I. Effect of microtubule stabilization and volume changing stresses on cytoskeletal remodeling. APL Bioeng. 2025;9:016102.
116. Iero M, Valenti R, Huber V, et al. Tumour-released exosomes and their implications in cancer immunity. Cell Death Differ. 2008;15:80-8.
117. Rontogianni S, Iskit S, van Doorn S, Peeper DS, Altelaar M. Combined EGFR and ROCK inhibition in triple-negative breast cancer leads to cell death via impaired autophagic flux. Mol Cell Proteomics. 2020;19:261-77.
118. Liang ZX, Liu HS, Wang FW, et al. LncRNA RPPH1 promotes colorectal cancer metastasis by interacting with TUBB3 and by promoting exosomes-mediated macrophage M2 polarization. Cell Death Dis. 2019;10:829.
119. Chen YD, Fang YT, Cheng YL, et al. Exophagy of annexin A2 via RAB11, RAB8A and RAB27A in IFN-γ-stimulated lung epithelial cells. Sci Rep. 2017;7:5676.
120. Guerra F, Bucci C. Role of the RAB7 protein in tumor progression and cisplatin chemoresistance. Cancers. 2019;11:1096.
121. Xu S, Cao B, Xuan G, et al. Function and regulation of Rab GTPases in cancers. Cell Biol Toxicol. 2024;40:28.
122. Ranieri R, Ciaglia E, Amodio G, et al. N6-isopentenyladenosine dual targeting of AMPK and Rab7 prenylation inhibits melanoma growth through the impairment of autophagic flux. Cell Death Differ. 2018;25:353-67.
123. Ning Y, Zheng M, Zhang Y, Jiao Y, Wang J, Zhang S. RhoA-ROCK2 signaling possesses complex pathophysiological functions in cancer progression and shows promising therapeutic potential. Cancer Cell Int. 2024;24:339.
124. de Sousa GR, Vieira GM, das Chagas PF, Pezuk JA, Brassesco MS. Should we keep rocking? Portraits from targeting Rho kinases in cancer. Pharmacol Res. 2020;160:105093.
125. Yakkala PA, Kamal A. Dual-targeting inhibitors involving tubulin for the treatment of cancer. Bioorg Chem. 2025;156:108116.
126. Lim S, Woo S, Lee KW, Kim KD. Roles of cytoskeleton in metastasis: from its mechanism to therapeutic strategies. Exp Mol Med. 2026;58:1-13.
127. Hu Y, Yan C, Mu L, et al. Fibroblast-derived exosomes contribute to chemoresistance through priming cancer stem cells in colorectal cancer. PLoS One. 2015;10:e0125625.
128. Catalano M, O'Driscoll L. Inhibiting extracellular vesicles formation and release: a review of EV inhibitors. J Extracell Vesicles. 2020;9:1703244.
129. Ha D, Yang N, Nadithe V. Exosomes as therapeutic drug carriers and delivery vehicles across biological membranes: current perspectives and future challenges. Acta Pharm Sin B. 2016;6:287-96.
130. Colombo M, Moita C, van Niel G, et al. Analysis of ESCRT functions in exosome biogenesis, composition and secretion highlights the heterogeneity of extracellular vesicles. J Cell Sci. 2013;126:5553-65.
131. Tomas A, Vaughan SO, Burgoyne T, et al. WASH and Tsg101/ALIX-dependent diversion of stress-internalized EGFR from the canonical endocytic pathway. Nat Commun. 2015;6:7324.
132. Koumangoye RB, Sakwe AM, Goodwin JS, Patel T, Ochieng J. Detachment of breast tumor cells induces rapid secretion of exosomes which subsequently mediate cellular adhesion and spreading. PLoS One. 2011;6:e24234.
133. Nishida-Aoki N, Tominaga N, Takeshita F, Sonoda H, Yoshioka Y, Ochiya T. Disruption of circulating extracellular vesicles as a novel therapeutic strategy against cancer metastasis. Mol Ther. 2017;25:181-91.
134. Shamseddine AA, Airola MV, Hannun YA. Roles and regulation of neutral sphingomyelinase-2 in cellular and pathological processes. Adv Biol Regul. 2015;57:24-41.
135. Mauthe M, Orhon I, Rocchi C, et al. Chloroquine inhibits autophagic flux by decreasing autophagosome-lysosome fusion. Autophagy. 2018;14:1435-55.
136. Fu Z, Cheng X, Kuang J, et al. CQ sensitizes human pancreatic cancer cells to gemcitabine through the lysosomal apoptotic pathway via reactive oxygen species. Mol Oncol. 2018;12:529-44.
137. Park D, Lee Y. Biphasic activity of chloroquine in human colorectal cancer cells. Dev Reprod. 2014;18:225-31.
138. Huang T, Song X, Yang Y, et al. Autophagy and hallmarks of cancer. Crit Rev Oncog. 2018;23:247-67.
139. Law BYK, Gordillo-Martínez F, Qu YQ, et al. Thalidezine, a novel AMPK activator, eliminates apoptosis-resistant cancer cells through energy-mediated autophagic cell death. Oncotarget. 2017;8:30077-91.
140. Rezazadeh D, Norooznezhad AH, Mansouri K, et al. Rapamycin reduces cervical cancer cells viability in hypoxic condition: investigation of the role of autophagy and apoptosis. Onco Targets Ther. 2020;13:4239-47.
141. Murrow L, Debnath J. ATG12-ATG3 connects basal autophagy and late endosome function. Autophagy. 2015;11:961-2.
142. Leidal AM, Debnath J. LC3-dependent extracellular vesicle loading and secretion (LDELS). Autophagy. 2020;16:1162-3.
143. Surana R, Morgado M, Somasundaram A, et al. Open-label, phase II trial of extracellular regulated kinase inhibition alone and in combination with autophagy inhibition in patients with metastatic pancreatic cancer. JCO Precis Oncol. 2025;9:e2500332.
144. Lee SM, Hewish M, Ahmed S, et al. Hydroxychloroquine in combination with platinum doublet chemotherapy as first-line treatment for extensive-stage small cell lung cancer (Study 15): a randomised phase II multicentre trial. Eur J Cancer. 2025;215:115162.
145. Goenka L, Dubashi B, Kayal S, et al. Targeting autophagy in platinum-sensitive relapsed ovarian cancer: randomized phase II trial of hydroxychloroquine with chemotherapy with biomarker correlation. Discov Oncol. 2025;16:203.
146. Wolpin BM, Rubinson DA, Wang X, et al. Phase II and pharmacodynamic study of autophagy inhibition using hydroxychloroquine in patients with metastatic pancreatic adenocarcinoma. Oncologist. 2014;19:637-8.
147. Piao S, Ojha R, Rebecca VW, et al. ALDH1A1 and HLTF modulate the activity of lysosomal autophagy inhibitors in cancer cells. Autophagy. 2017;13:2056-71.
148. Kalli M, Mpekris F, Charalambous A, et al. Mechanical forces inducing oxaliplatin resistance in pancreatic cancer can be targeted by autophagy inhibition. Commun Biol. 2024;7:1581.
149. Thakur PC, Miller-Ocuin JL, Nguyen K, et al. Inhibition of endoplasmic-reticulum-stress-mediated autophagy enhances the effectiveness of chemotherapeutics on pancreatic cancer. J Transl Med. 2018;16:190.
150. Yuan Y, Li D, Li H, Wang L, Tian G, Dong Y. YAP overexpression promotes the epithelial-mesenchymal transition and chemoresistance in pancreatic cancer cells. Mol Med Rep. 2016;13:237-42.
151. D'Souza AI, Grover R, Monzon GA, Santen L, Diez S. Vesicles driven by dynein and kinesin exhibit directional reversals without regulators. Nat Commun. 2023;14:7532.
152. Vishnubhotla R, Bharadwaj S, Sun S, Metlushko V, Glover SC. Treatment with Y-27632, a ROCK inhibitor, increases the proinvasive nature of SW620 cells on 3D collagen type 1 matrix. Int J Cell Biol. 2012;2012:259142.
153. Gu YY, Yu J, Zhang JF, Wang C. Suppressing the secretion of exosomal miR-19b by gw4869 could regulate oxaliplatin sensitivity in colorectal cancer. Neoplasma. 2019;66:39-45.
154. Mohammad N, Malvi P, Meena AS, et al. Cholesterol depletion by methyl-β-cyclodextrin augments tamoxifen induced cell death by enhancing its uptake in melanoma. Mol Cancer. 2014;13:204.
155. Luga V, Zhang L, Viloria-Petit AM, et al. Exosomes mediate stromal mobilization of autocrine Wnt-PCP signaling in breast cancer cell migration. Cell. 2012;151:1542-56.
156. Brown SR, Radcliffe ME, Danner JT, et al. Extracellular vesicle-mediated modulation of stem-like phenotype in breast cancer cells under fluid shear stress. Biomolecules. 2024;14:757.
